Biography:
Carolyn Cross, M.S.C., CFA, MBA, Founder and Chief Executive Officer of Ondine Biomedical Inc., a global leader in photodisinfection technologies for infection prevention and antimicrobial resistance. With more than two decades of experience advancing non‑antibiotic medical innovations, she has led translational research collaborations across leading academic and clinical institutions worldwide. Ms. Cross has served on Canada’s National Research Council and the Board of the Canadian Foundation for Innovation, shaping national strategies in biomanufacturing and research excellence.
Title : Breaking the mupirocin paradox: Light activated nasal decolonization achieves 66% SSI reduction and sustained cost savings without resistance signals in spine surgery over 8 years
Title : The double whammy of cardiac SSI under-reporting: Correcting incidence and inflation to unlock capacity and eradicate AMR debt